Centogene (NASDAQ:CNTG) Short Interest Update

Centogene (NASDAQ:CNTG) was the target of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 11,300 shares, a decline of 56.7% from the February 29th total of 26,100 shares. Based on an average daily volume of 24,200 shares, the short-interest ratio is presently 0.5 days. Approximately 0.1% of the shares of the company are short sold.

Centogene Trading Up 2.9 %

Centogene stock traded up $0.02 during trading hours on Thursday, hitting $0.71. The stock had a trading volume of 34,037 shares, compared to its average volume of 37,878. The company has a 50-day moving average of $0.89 and a two-hundred day moving average of $1.06. Centogene has a fifty-two week low of $0.60 and a fifty-two week high of $2.52.

About Centogene

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases.